An international collaborative research effort led by scientists from Washington University, St. Louis, Baylor College of Medicine, Houston, and Johns Hopkins University, Baltimore, has taken a multi-omic approach to better understand the the elusive molecular triggers of pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive form of cancer and chances of survival are poor.
The team analyzed the proteomes and genomes of 140 pancreatic cancers and compared the data to 67 normal surrounding tissues, and 9 pancreatic ductal tissues and detailed their findings in an article published in Cell. Read more . . .